Keywords: AstraZeneca, Galderma, R&D collaboration, Dermatologicals

AstraZeneca and Galderma link up for new dermatological treatments

Article | 08 March 2011

Print This

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and Switzerland’s Galderma Pharma have entered into a R&D collaboration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in